Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

BioChem Pharma to challenge Epivir patent

Aug. 9, 1996

A-76202: Alpha-glucosidase/sucrase-isomaltase complex inhibitor from Sankyo

Aug. 9, 1996

Emory University files Epivir patent infringement action

Aug. 9, 1996

Study of Epivir's effect on HIV survival and disease progression terminated

Aug. 9, 1996

Emory University issued U.S. patent covering Epivir

Aug. 9, 1996

Vistide available in U.S. as CMV treatment in AIDS patients

July 26, 1996

rBCG-V3JI: Ajinomoto's vector-based vaccine

July 26, 1996

Immunogenic oligomeric HIV-1 gp160 vaccine described

July 26, 1996

Rz9456: Potential hematopoietic stem cell therapy for AIDS

July 26, 1996

Cyanovirin-N selected for high priority development by the National Cancer Institute

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...